Conatus Pharmaceuticals Inc. Termination Agreements

6 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Conversion, Termination and Release Agreement, dated August 10, 2016, by and among Histogen Inc., Jonathan Jackson, Lordship Ventures LLC and Lordship Ventures Histogen Holdings...
Termination Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
DE
2020
Notice of Termination and Letter Agreement, dated September 18, 2023, by and between the Company and Joyce Reyes
Termination Agreements
Conatus Pharmaceuticals Inc.
2023
Notice of Termination and Letter Agreement, dated September 18, 2023, by and between the Company and Alfred P. Spada
Termination Agreements
Conatus Pharmaceuticals Inc.
2023
Notice of Termination and Letter Agreement, dated September 18, 2023 by and between the Company and Steven J. Mento
Termination Agreements
Conatus Pharmaceuticals Inc.
2023
Termination of Stockholder Agreements, dated January 28, 2020, by and among Histogen Inc., Lordship Ventures Histogen Holdings LLC, Pineworld Capital Limited, Gail K. Naughton,...
Termination Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
DE
2020
Settlement, Release and Termination Agreement, dated April 5, 2019, by and among Histogen Inc., PUR Biologics, LLC, Wylde, LLC, Christopher Wiggins and Ryan Fernan
Termination Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
CA
2020